MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with D

Desloratadine

Desloratadine 5mg tablets

Use with caution

Stability notes for Desloratadine 5mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA.   Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products Neoclarityn 5mg film-coated tablets (Organon Pharma (UK) Limited) and desloratadine 5mg film-coated tablets (Mylan).

Suppliers (12) of Desloratadine 5mg tablets
Desloratadine 5mg tablets (A A H Pharmaceuticals Ltd)
Desloratadine 5mg tablets (Alliance Healthcare (Distribution) Ltd)
Desloratadine 5mg tablets (Bristol Laboratories Ltd)
Desloratadine 5mg tablets (Crescent Pharma Ltd)
Desloratadine 5mg tablets (Krka UK Ltd)
Desloratadine 5mg tablets (Manx Healthcare Ltd)
Desloratadine 5mg tablets (Medihealth (Northern) Ltd)
Desloratadine 5mg tablets (Phoenix Healthcare Distribution Ltd)
Desloratadine 5mg tablets (Rivopharm (UK) Ltd)
Desloratadine 5mg tablets (Sigma Pharmaceuticals Plc)
Desloratadine 5mg tablets (Viatris UK Healthcare Ltd)
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.